R
Redhill Biopharma Ltd D
D
RDHL
2.64000
USD
0.71
(36.79%)
قبل الجلسة
حجم التداول
8
الربح لكل سهم
-1
العائد الربحي
-
P/E
-0
حجم السوق
4,625,298
الأخبار المقالات
العنوان: Redhill Biopharma Ltd
القطاع: Healthcare
الصناعة: Drug Manufacturers - Specialty & Generic
Redhill Biopharma Ltd is a specialty biopharmaceutical company focused on gastrointestinal diseases. The company is focused primarily on the advancement of its development pipeline of clinical-stage therapeutic candidates. The company alsocommercializes in the U.S. GI-related products, Talicia (omeprazole, amoxicillin, and rifabutin) and Aemcolo (rifamycin). The company's current pipeline consists of five therapeutic candidates, which are Opaganib, RHB-107, RHB-102, RHB-204, and RHB-104, most of which are in clinical development.